Alliance Management Consulting and Training, Partnering Frameworks and Tools, Collaborative Leadership

Partnering Readiness: The New Strategic Leadership Agenda for Partnering Professionals
2. Thought Leadership / December 30th, 2019
download the pdf 
The final Strategic Alliance Quarterly of the decade features our article introducing the Partnering Readiness Stack, our outcome focused-approach to bring in agility, reduce the inefficiencies in partnering and ensure that the rhythms of partnering are not met with unnecessary friction and hurdles, whether in low-touch or high-touch, one-to-one, multipartner networks, or ecosystem arrangements.

Using data generated from interviews, a survey, and workshops with ASAP members, we share participants’ assessments of their current state of readiness and an overview of some of the initiatives they are undertaking. In the partnering everywhere world, the new strategic leadership agenda goes well beyond “partner of choice” and “centers of excellence” and requires knocking down barriers to collaboration, obliterating silos, and transforming the enterprise to enable a holistic, integrated partnering capability.
Optimize The Portfolio to Drive Growth
5. Case Studies / December 22nd, 2017
A change in strategy in this software company led to a rethinking of partnering strategy and a realization that 90% of business was coming from 10% of the partner portfolio....
Outsourced Service Providers or An Ecosystem of Strategic Partners?
1. Partnering Guide / August 30th, 2017
AUTHOR: Jan Twombly
download pdf

The July/August issue of Pharmaceutical Outsourcing features our recent article on building the mindset, skillset, and toolset to collaborate with providers—and maximize the performance of your biopharma ecosystem.


The article highlights Forma Therapeutics, a quickly growing integrated drug discovery and development company, that has a very collaborative and innovative culture that clearly works to its benefit. The Company just announced an extension of its 2014 collaboration with Celgene to “evaluate additional therapeutic candidates across important emerging target families in the areas of protein homeostasis, inflammation & immunology, and neuro...
Top